GRF/P SM stock pitch

Added to YB: 2024-03-22

Pitch date: 2024-03-22

Grifols, S.A.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Market Cap

EUR 6.5B

Pitch Price

EUR 7.81

Price Target

N/A

Dividend

2.81%

EV/EBITDA

4.98

P/E

19.49

EV/Sales

1.21

Sector

Biotechnology

A summary for this pitch has not been created yet.